Fiat Chrysler Automobiles N.V. (NYSE:FCAU) has selected two 17-inch versions of Nexen Tire Corp.’s CP671 tire for North American-bound Fiat 500X crossover utility vehicles, which are slated to go into production in February. On Wednesday shares of Fiat Chrysler Automobiles N.V. (NYSE:FCAU) closed at $13.96. Company’s sales growth for last 5 years was 7.80% and EPS growth for next 5 years is recorded as 2.00%.
BIND Therapeutics, Inc. (NASDAQ:BIND), announced that it is commencing an underwritten public offering of units consisting of shares of BIND’s common stock and warrants to purchase shares of BIND’s common stock. All of the units in the offering are to be sold by BIND. BIND Therapeutics, Inc. (NASDAQ:BIND) in last trading activity moved down -6.90% to close at $6.34. Company weekly performance is -10.96% while its quarterly performance stands at -20.75%. BIND Therapeutics, Inc. (NASDAQ:BIND) is -57.02% away from its 52 week high.
Research analysts at BB&T Corp. initiated coverage on shares of Cal-Maine Foods (NASDAQ:CALM) in a report released on Friday. The firm set a “hold” rating on the stock. On last trading day Cal-Maine Foods, Inc. (NASDAQ:CALM) increased 2.04% to close at $36.53. Its volatility for the week is 3.95% while volatility for the month is 3.97%. CALM’s sales growth for past 5 years was 9.20% and its EPS growth for past 5 years was 6.20%. Cal-Maine Foods, Inc. (NASDAQ:CALM) monthly performance is -2.66%.
Barrett Business Services Inc. (NASDAQ:BBSI) reported Net revenues in the fourth quarter of 2014 increased 21% to $175.0 million compared to $144.5 million in the fourth quarter of 2013.Barrett Business Services Inc. (NASDAQ:BBSI) has 1.80% insider ownership while its institutional ownership stands at 94.00%. In last trading activity company’s stock closed at $35.30.
Pharmacyclics Inc. (NASDAQ:PCYC) on 30 January announced a label expansion for its drug Imbruvica in the U.S. Imbruvica gained FDA approval for all lines of therapy for the treatment of patients suffering from Waldenstrom’s macroglobulinemia (WM). On last trading day Pharmacyclics Inc. (NASDAQ:PCYC) increased 0.41% to close at $161.89. Its volatility for the week is 5.64% while volatility for the month is 4.09%. PCYC’s EPS growth for past 5 years was 24.50%. Pharmacyclics Inc. (NASDAQ:PCYC) monthly performance is 34.94%.